These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14621193)

  • 21. Immunohistochemical markers for Barrett's esophagus and associations to esophageal Z-line appearance.
    Wallner B; Sylvan A; Janunger KG; Bozoky B; Stenling R
    Scand J Gastroenterol; 2001 Sep; 36(9):910-5. PubMed ID: 11521979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Endoscopic diagnosis of Barrett's esophagus].
    Hoshihara Y; Kogure T; Yamamoto T; Hashimoto M; Hoteya O
    Nihon Rinsho; 2005 Aug; 63(8):1394-8. PubMed ID: 16101228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokeratin and CDX-2 expression in Barrett's esophagus.
    van Baal JW; Bozikas A; Pronk R; Ten Kate FJ; Milano F; Rygiel AM; Rosmolen WD; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Scand J Gastroenterol; 2008; 43(2):132-40. PubMed ID: 18224560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controversies of the cardiac mucosa and Barrett's oesophagus.
    Chandrasoma P
    Histopathology; 2005 Apr; 46(4):361-73. PubMed ID: 15810947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunopathological patterns of the stomach in adenocarcinoma of the esophagus, cardia, and gastric antrum: gastric profiles in Siewert type I and II tumors.
    Mattioli S; Ruffato A; Di Simone MP; Corti B; D'Errico A; Lugaresi ML; Mattioli B; D'Ovidio F
    Ann Thorac Surg; 2007 May; 83(5):1814-9. PubMed ID: 17462405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoreactivity of cytokeratins 7 and 20 in goblet cells and columnar blue cells in patients with endoscopic evidence of Barrett's esophagus.
    Cantarelli JC; Fagundes RB; Meurer L; Rocha MP; Nicola A; Kruel CD
    Arq Gastroenterol; 2009; 46(2):127-31. PubMed ID: 19578614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach.
    Ormsby AH; Goldblum JR; Rice TW; Richter JE; Falk GW; Vaezi MF; Gramlich TL
    Hum Pathol; 1999 Mar; 30(3):288-94. PubMed ID: 10088547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytokeratin 7 and 20 in Barrett's esophagus].
    Arra A; Nieva NB; Rey N; Fernández AO
    Rev Fac Cien Med Univ Nac Cordoba; 2005; 62(3):57-62. PubMed ID: 16972735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Histochemical diagnosis of short segment Barrett's esophagus].
    Fujiyama Y; Ishizuka I; Koyama S
    Nihon Rinsho; 2005 Aug; 63(8):1420-6. PubMed ID: 16101233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis resistance in Barrett's esophagus: ex vivo bioassay of live stressed tissues.
    Dvorakova K; Payne CM; Ramsey L; Bernstein H; Holubec H; Chavarria M; Bernstein C; Sampliner RE; Riley C; Prasad A; Garewal H
    Am J Gastroenterol; 2005 Feb; 100(2):424-31. PubMed ID: 15667503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI.
    Glickman JN; Wang H; Das KM; Goyal RK; Spechler SJ; Antonioli D; Odze RD
    Am J Surg Pathol; 2001 Jan; 25(1):87-94. PubMed ID: 11145256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of cytokeratin immunoreactivity pattern for distinction of Barrett's esophagus from intestinal metaplasia of the stomach.
    Iwata T; Kurita N; Nishioka M; Hidenori M; Wakatsuki S; Sano T; Shimada M
    Hepatogastroenterology; 2007 Sep; 54(78):1710-2. PubMed ID: 18019700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
    Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
    Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Barrett esophagus by multiphoton microscopy.
    Chen J; Wong S; Nathanson MH; Jain D
    Arch Pathol Lab Med; 2014 Feb; 138(2):204-12. PubMed ID: 24476518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
    Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D
    Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What the gastroenterologist needs to know about the histology of Barrett's esophagus.
    Odze RD
    Curr Opin Gastroenterol; 2011 Jul; 27(4):389-96. PubMed ID: 21543978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenocarcinoma of the upper esophagus arising in heterotopic gastric mucosa: common pathogenesis with Barrett's adenocarcinoma?
    Chatelain D; de Lajarte-Thirouard AS; Tiret E; Flejou JF
    Virchows Arch; 2002 Oct; 441(4):406-11. PubMed ID: 12516606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ErbB2 without erbB3 expression in metaplastic columnar epithelium of Barrett's esophagus.
    Nishigaki H; Wada K; Tatsuguchi A; Sueoka N; Futagami S; Gudis K; Miyake K; Tsukui T; Sakamoto C
    Digestion; 2004; 70(2):95-102. PubMed ID: 15375338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expression of 8-hydroxydeoxyguanosine in oesophageal tissues and tumours.
    Räsänen JV; Sihvo EI; Ahotupa MO; Färkkilä MA; Salo JA
    Eur J Surg Oncol; 2007 Dec; 33(10):1164-8. PubMed ID: 17467227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of intestinal metaplasia in gastric cardia and Barrett's esophagus.
    Miao Q; Peng YS; Cai GH; Chen XY
    J Dig Dis; 2011 Aug; 12(4):272-8. PubMed ID: 21791021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.